Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip D Home

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Diabetes Care|January 22, 2017
Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016:39;363-370Philip D Home
Diabetes Care|September 26, 2013
Validity of meta-analysis in diabetes: we need to be aware of its limitationsPhilip D Home
Diabetes Care|June 27, 2013
Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147Philip D Home
Diabetes, Obesity & Metabolism|March 4, 2025
An overview of insulin therapy for the non-specialistPhilip D Home
Diabetes Research and Clinical Practice|May 15, 2010
How can observational trials inform and improve clinical practice?Philip D Home
Evidence-Based Medicine|November 18, 2010
Low-dose rosiglitazone plus metformin reduces risk of incident type 2 diabetes compared with placebo in people with impaired glucose tolerancePhilip D Home
Clinical Medicine (London, England)|September 5, 2009
Management of type 2 diabetes: NICE guidelinesLatika Sibal, Philip D Home
The Lancet. Diabetes & Endocrinology|September 4, 2021
Insulin therapy development beyond 100 yearsPhilip D Home, Roopa Mehta
Diabetes/Metabolism Research and Reviews|September 27, 2002
An overview of insulin glarginePhilip D Home, Simon G Ashwell
Diabetes Care|July 22, 2016
Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?Francesco Giorgino, Philip D Home, Jaakko Tuomilehto
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Diabetes Care|January 22, 2017
Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016:39;363-370Philip D Home
Diabetes Care|September 26, 2013
Validity of meta-analysis in diabetes: we need to be aware of its limitationsPhilip D Home
Diabetes Care|June 27, 2013
Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147Philip D Home
Diabetes, Obesity & Metabolism|March 4, 2025
An overview of insulin therapy for the non-specialistPhilip D Home
Diabetes Research and Clinical Practice|May 15, 2010
How can observational trials inform and improve clinical practice?Philip D Home
Evidence-Based Medicine|November 18, 2010
Low-dose rosiglitazone plus metformin reduces risk of incident type 2 diabetes compared with placebo in people with impaired glucose tolerancePhilip D Home
Clinical Medicine (London, England)|September 5, 2009
Management of type 2 diabetes: NICE guidelinesLatika Sibal, Philip D Home
The Lancet. Diabetes & Endocrinology|September 4, 2021
Insulin therapy development beyond 100 yearsPhilip D Home, Roopa Mehta
Diabetes/Metabolism Research and Reviews|September 27, 2002
An overview of insulin glarginePhilip D Home, Simon G Ashwell
Diabetes Care|July 22, 2016
Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?Francesco Giorgino, Philip D Home, Jaakko Tuomilehto
Pageof 7